Marshall M N, Shekelle P G, Leatherman S, Brook R H
School of Postgraduate Medicine and Health Sciences, University of Exeter, England, UK.
JAMA. 2000 Apr 12;283(14):1866-74. doi: 10.1001/jama.283.14.1866.
Information about the performance of hospitals, health professionals, and health care organizations has been made public in the United States for more than a decade. The expected gains of public disclosure have not been made clear, and both the benefits and potential risks have received minimal empirical investigation.
To summarize the empirical evidence concerning public disclosure of performance data, relate the results to the potential gains, and identify areas requiring further research.
A literature search was conducted on MEDLINE and EMBASE databases for articles published between January 1986 and October 1999 in peer-reviewed journals. Review of citations, public documents, and expert advice was conducted to identify studies not found in the electronic databases.
Descriptive, observational, or experimental evaluations of US reporting systems were selected for inclusion.
Included studies were organized based on use of public data by consumers, purchasers, physicians, and hospitals; impact on quality of care outcomes; and costs.
Seven US reporting systems have been the subject of published empirical evaluations. Descriptive and observational methods predominate. Consumers and purchasers rarely search out the information and do not understand or trust it; it has a small, although increasing, impact on their decision making. Physicians are skeptical about such data and only a small proportion makes use of it. Hospitals appear to be most responsive to the data. In a limited number of studies, the publication of performance data has been associated with an improvement in health outcomes.
There are several potential gains from the public disclosure of performance data, but use of the information by provider organizations for quality improvement may be the most productive area for further research.
在美国,有关医院、医疗专业人员和医疗保健机构绩效的信息已公开十多年。公开披露的预期收益尚不明朗,其益处和潜在风险都很少得到实证研究。
总结有关绩效数据公开披露的实证证据,将结果与潜在收益相关联,并确定需要进一步研究的领域。
在MEDLINE和EMBASE数据库中检索1986年1月至1999年10月期间发表在同行评审期刊上的文章。对参考文献、公共文件和专家建议进行审查,以识别电子数据库中未找到的研究。
选择对美国报告系统进行的描述性、观察性或实验性评估纳入研究。
纳入的研究根据消费者、购买者、医生和医院对公共数据的使用情况;对医疗质量结果的影响;以及成本进行组织。
七个美国报告系统已成为已发表实证评估的对象。描述性和观察性方法占主导地位。消费者和购买者很少查找这些信息,也不理解或信任这些信息;它对他们的决策影响很小,尽管这种影响在增加。医生对这类数据持怀疑态度,只有一小部分人会使用它。医院似乎对这些数据反应最为积极。在少数研究中,绩效数据的公布与健康结果的改善有关。
绩效数据的公开披露有几个潜在的好处,但提供者组织将这些信息用于质量改进可能是进一步研究最有成效的领域。